Dental Materials
Volume 29, Issue 2 , Pages 191-198, February 2013
Abstract
Objective
The objective of this 6 year
prospective randomized equivalence trial was to evaluate the long-term
clinical performance of a new nano-hybrid resin composite (RC) in Class
II restorations in an intraindividual comparison with its
well-established conventional hybrid RC predecessor.
Methods
Each
of 52 participants received at least two, as similar as possible, Class
II restorations. The cavities were chosen at random to be restored with
an experimental nano-hybrid RC (Exite/Tetric EvoCeram (TEC);
n=
61) and a conventional hybrid RC (Exite/Tetric Ceram (TC);
n=
61). The restorations were evaluated with slightly modified USPHS criteria at baseline and then annually during 6 years.
Results
Two
patient drop outs with 4 restorations (2TEC, 2TC) were registered
during the follow-up. A prediction of the caries risk showed that 16 of
the evaluated 52 patients were considered as high risk patients. Eight
TEC (2 P, 6M) and 6 TC (2P, 4M) restorations failed during the 6 years.
The main reason of failure was secondary caries (43%; including the
failure fracture
+
secondary
caries it increases to 57.1%). 63% of the recurrent caries lesions were
found in high caries risk participants. The overall success rate at six
years was 88.1%. No statistical significant difference was found in the
overall survival rate between the two investigated RC.
Significance
The
nano-hybrid RC showed good clinical performance during the 6 year
evaluation, comparable to the well-established conventional hybrid RC.
Comments